Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL126225

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
C/N=C(\NC)NC1=NC2=C3C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)CC/C=C(\C)C(=O)NC(=CC2=N1)C3=O

Basic Information

ChEMBL ID CHEMBL126225
Phase Preclinical
Structure Type MOL
InChI Key WMEFBCOXNXFSDR-LNCIKYFRSA-N
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names

Molecular Properties

641.8
MW (Da)
2.02
ALogP
10
HBA
5
HBD
198.3
PSA (Ų)
0.13
QED
1
Ro5 Violations
3
Rot. Bonds

Drug Information

Molecule Type Small molecule
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C32H47N7O7
MW 641.77
Aromatic Rings 0
Heavy Atoms 46
NP-Likeness 1.66

Activity Summary

IC50 1 meas. best 7.3

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
SK-BR-3
CHEMBL613834
IC50 7.3 7.3 50.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
SK-BR-3 IC50 = 50.0 nM 7.3 Inhibition of oncogene product p185 erbB-2 from human breast cancer cells(SK-BR-... 7562911

Literature References

PubMed DOI Target Context # Activities
7562911 10.1021/jm00019a010 SK-BR-3 1

Data from ChEMBL 36 via Core Engine